News & Media
We work quietly, as do our highly efficient products. Our success does speak in ways loud and clear. It finds itself into prominence across Indian and international platforms of promotion.
SMT Launches Hydra™ TAVI System in Russia, Offering Advanced Care for Aortic Stenosis Patients
SMT Launches Hydra Transcatheter Aortic Valve Replacement (TAVR) System in Mexico, Expanding Global Reach
Landmark results from S-FLEX UK-II registry published in BMJ Open: Supraflex Cruz demonstrates outstanding performance
Singapore approves novel Hydra TAVI system
Supraflex Cruz RCT in High bleeding Risk patients now published in Circulation
SMT gets TGA Australia approval for Supraflex Cruz
SMT announces completion of patient enrolment for Tuxedo-2 trial
SMT won the Italian National CONSIP 2-Year Tender to Supply Hydra TAVI in All Italian Hospitals
GENESIS-II Study Reveals Promising 30-Day Results
SMT and HeartX Forge Transformative Partnership in Cardiovascular Space
Promising Safety and Efficacy Results for Supraflex Cruz
Positive Results Revealed In Clinical Trial COMPARE 60-80 for HBR Patients
SMT Announces Positive Results of S-Flex UK-II Registry at TCT 2023
SMT unveils Supraflex Cruz stent data at ESC Congress 2023
Fire Trial Shows Positive Results, presented at ESC Congress 2023
SMT announces late-breaking data of its Supraflex Cruz stent at ESC Congress 2023
SMT's MD receives ET 40 Under Forty Award
SMT chosen as exclusive distributor of Penumbra’s latest mechanical and computer-aided aspiration technology in India to address blood clots in the heart and body
Kotak Pre-IPO fund buys minority stake in stent maker SMT
SMT Receives India Pharma Award for DCB Peripherics
First 1,000 Patients enrolled in Cruz Senior Trial
National Science Day Award – by the Government of India
SMT announces positive results from study on heart valve’s performance
SMT announces positive results from Hydra transcatheter aortic heart valve
SMT announces positive results of Hydra Transcatheter Aortic Heart Valve
SMT announces positive results of Hydra™ Transcatheter Aortic Heart Valve published in JACC
SMT Announces Positive Results for Hydra Transcatheter Aortic Heart Valve
SMT’s Supraflex Cruz DES Evaluated in European CRUZ SENIOR Trial of Octo- and Nonagenarian Patients
Cruz Senior trial starts with Supraflex Cruz in Europe
Cruz Senior trial starts with Supraflex Cruz in Europe
Cruz Senior trial starts with Supraflex Cruz in Europe
Cruz Senior trial starts with Supraflex Cruz in Europe
Hydra self-expanding aortic valve shows positive results in the Genesis Study
Hydra Self-Expanding Aortic Valve Shows Positive Results in the Genesis Study
SMT’s Hydra Self-Expanding TAVR Device Evaluated in Published GENESIS Study
Hydra Self-Expanding Aortic Valve Shows Positive Results in the Genesis Study
Back to Growth: Interview with Ganesh Sabat, CEO, Sahajanand Medical Technologies Pvt. Ltd.
The Novel Hydra Transcatheter Aortic Valve Demonstrates Favourable Hemodynamic and Low Pacemaker Rate
The Novel Hydra Transcatheter Aortic Valve Demonstrates Favourable Hemodynamic and Low Pacemaker Rate
The Novel Hydra Transcatheter Aortic Valve Demonstrates Favourable Hemodynamic and Low Pacemaker Rate
The Novel Hydra Transcatheter Aortic Valve Demonstrates Favourable Hemodynamic and Low Pacemaker Rate
SMT Completes Enrolment of Cruz HBR Registry
SMT Completes Enrolment of Cruz HBR Registry
SMT Completes Enrolment of Cruz HBR Registry
SMT Completes Enrolment of Cruz HBR Registry
SMT Completes Enrolment of Cruz HBR Registry
SMT Completes Enrolment of Cruz HBR Registry
SMT Completes Enrolment of Cruz HBR Registry
SMT launches TAVR device Hydra in Central Europe
Hydra TAVR device receives CE Mark
Hydra TAVR System Receives CE Mark Approval to Treat Aortic Stenosis
SMT’s Hydra TAVR System Receives CE Mark Approval
SMT receives CE mark approval for Hydra TAVR System to treat aortic stenosis
Hydra TAVR System Receives CE Mark Approval to Treat Aortic Stenosis
SMT’s TAVR wins CE Mark for aortic stenosis
Hydra TAVR System Receives CE Mark Approval to Treat Aortic Stenosis
SMT’s TAVR wins CE Mark for aortic stenosis
Hydra TAVR device receives CE Mark approval for treatment of aortic stenosis
Hydra TAVR System Receives CE Mark Approval to Treat Aortic Stenosis
SMT announces entry in Structural Heart Segment with the acquisition of Vascular Concepts
Sahajanand Medical Technologies Acquires Vascular Concepts
Gujarat-based SMT announces acquisition of Vascular Concepts
SMT acquires Vascular Concepts
Morgan Stanley PE-backed stent maker Sahajanand acquires Vascular Concepts
SMT Enters Structural Heart Market With Acquisition of Vascular Concepts
Stent maker SMT acquires Vascular Concepts to foray into transcatheter heart valves
SMT announces entry into Structural Heart Segment with the acquisition of Vascular Concepts
SMT acquires Vascular Concepts to make foray into structural heart segment
SMT Announces Entry Into Structural Heart Segment With the Acquisition of Vascular Concepts
SMT Announces Entry Into Structural Heart Segment With the Acquisition of Vascular Concepts
SMT Announces Entry Into Structural Heart Segment With the Acquisition of Vascular Concepts
Medical equipment industry may struggle to keep up with demand
Safeguarding the COVID-19 warriors
Medical devices sector to get big push in Telangana
Meet 5 entrepreneurs who set up multi-crore businesses in India’s growing healthcare sector
Foundation laid for Asia’s largest stent unit in Hyderabad
With Rs 980 crore investment, Telangana sets mark in medical-technology industry
Foundation laid for Asia’s largest stent unit in Hyderabad
Foundation laid for Asia’s largest stent unit in Hyderabad
Hyderabad to become ‘Medical’ devices hub soon
Asia’s largest stent manufacturing facility to come up in Telangana
Stone laid for Rs 250-cr stent manufacturing unit in Sangareddy
Hyderabad: Mega stent plant set up in state
Stone laid for 250-cr stent-making unit
Asia’s biggest stent unit to be set up in Telangana
Etela To Lay Stone For Stent Manufacturing Unit Today
Asia’s biggest stent unit to be set up in Telangana
SMT to set up Asias largest Stent Manufacturing unit in T-dist
Hyderabad will be medical devices hub soon: KTR
Etala to lay stone for Stent Manufacturing Unit on September 1
SMT Bags Italy Tender
SMT Bags Tender From Italy
Industry Story
Desi medical devices firms expand footprint, lock horns with global giants
Video Interaction
SMT global records 60 percent growth in FY17-18, not planning for listing anytime soon
Telangana Manufacturing Unit
Asia’s biggest stent unit for Telangana
Asia’s largest stent manufacturing unit to come up in Telangana
SMT to set up ₹250-cr stent unit
Dr Kaul's interaction with PTI
Made in India coronary stents as good as foreign ones: Study
Dr Kaul's interaction with PTI
Made in India coronary stents as good as foreign ones: Study
Made in India coronary stents as good as foreign ones: Study
Made in India coronary stents as good as foreign ones: Study
Made in India coronary stents as good as foreign ones: Study
Feature Story
SMT aims to be one of top-three stent players in Europe, eyes Tier-I cities
RESULT ANNOUNCEMENT
SMT aims to be one of top-three stent players in Europe, eyes Tier-I cities
Surat-made stent clinically at par with Abbott’s, says global study
TCTMD
TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers
Seven Year Clinical Outcome- Trail conducted by Dr. Abhyankar
SMT announces result of Biodegradable Polymer Coated Supralimus Sirolimus-Eluting Stent’s clinical study
S-Flex registry in Netherlands
SMT starts S-Flex Registry in Netherlands
Govt.'s healthcare and S&T policies forward looking: Industry
Quote
Import of medical devices from US on the rise
Coverage on SMT - Cordis strategic partnership
SMT and Cardinal Health enter into a strategic partnership for the Indian market
SMT and Cardinal Health enter into a strategic partnership for the Indian market
Online coverage - Completion of Ever OCT Study
SMT announces completion of patient enrolment of EverOCT* Trial
Surat firm aims to topple Abbott to become number one stent maker
SMT announces completion of patient enrolment of EverOCT Trial
Online coverage -Company Interaction
SMT announces completion of patient enrolment of EverOCT* Trial
Online coverage - Post NPPA
US stents dip in distribution in India after price caps
Local stent makers welcome NPPA price ceiling
Surgical strike! Prices of drug eluting stents cut
Local stent makers welcome NPPA price ceiling
Local stent makers welcome NPPA price ceiling
Online coverage - Pre NPPA
Prove superiority for differential pricing, NPPA tells pharma companies
Differential pricing of stents, a moot talking point between industry and NPPA
Online coverage - Budget Quote
Industry reacts to FM Jaitley's Health Budget
Online coverage - SMT announces positive results from the S flex UK Registry
SMT announces positive results from the S flex UK Registry
SMT announces positive results from the S flex UK Registry
Online coverage - Morgan Stanley
SMT (Sahajanand Medical Technologies) Raises INR 230 Crores of Equity Capital in a Round Led by a Fund Managed by Morgan Stanley Private Equity Asia
SMT (Sahajanand Medical Technologies) Raises INR 230 Crores of Equity Capital in a Round Led by a Fund Managed by Morgan Stanley Private Equity Asia
Sahajanand Medical raises Rs 230 crore
Stent maker Sahajanand gets $36 mn injection from Morgan Stanley, Samara
Sahajanand Medical Technologies Raises 2.30 Bln Rupees In Funding Round
SMT raises Rs 230-cr from Morgan Stanley, Samara Capital
India: Morgan Stanley PE picks minority stake in Sahajanand Medical
Domestic stent manufacturer SMT raises Rs 250 crore from Morgan Stanley PE & Samara Capital
Online coverage - Company Interaction
With proper government support India can rule medical device sector
Online coverage - SMT Bags 2 years contract with Italian Public Hospital for 10,000 DES
SMT bags 2 years contract with Italian Public Hospitals for 10,000 DES
SMT bags 2 years contract with Italian Public Hospitals for 10,000 DES
SMT bags 2 years contract with Italian Public Hospitals for 10,000 DES
Sahajanand Medical Technologies Appoints Harvinder Singh and Priyanka Cohen to its Board of Directors
SMT Welcomes Bhargav Kotadia as CEO, Building on Strong Legacy
SMT Launches Hydra™ TAVI System in Russia, Offering Advanced Care for Aortic Stenosis Patients
SMT Launches Hydra Transcatheter Aortic Valve Replacement (TAVR) System in Mexico, Expanding Global Reach
Landmark results from S-FLEX UK-II registry published in BMJ Open: Supraflex Cruz demonstrates outstanding performance
Singapore approves novel Hydra TAVI system
Supraflex Cruz RCT in High bleeding Risk patients now published in Circulation
SMT gets TGA Australia approval for Supraflex Cruz
SMT announces completion of patient enrolment for Tuxedo-2 trial
SMT won the Italian National CONSIP 2-Year Tender to Supply Hydra TAVI in All Italian Hospitals
GENESIS-II Study Reveals Promising 30-Day Results
SMT and HeartX Forge Transformative Partnership in Cardiovascular Space
Promising Safety and Efficacy Results for Supraflex Cruz
Positive Results Revealed in Clinical Trial COMPARE 60/80 for High Bleeding Risk Patients
SMT announces positive results of S-Flex UK-II Registry at TCT 2023
Fire Trial Shows Positive Results, Presented at ESC Congress 2023
SMT's MD receives ET 40 Under Forty Award
SMT Chosen as Exclusive Distributor of Penumbra’s Latest Mechanical and Computer-Aided Aspiration Technology in India to Address Blood Clots in the Heart and Body
SMT receives India Pharma 2022 Award for DCB ‘Peripherics’
First 1,000 Patients enrolled in Cruz Senior Trial
National Science Day Award – by the Government of India
SMT announces positive results of Hydra™ Transcatheter Aortic Heart Valve published in JACC
Cruz Senior trial starts with Supraflex Cruz in Europe
Cruz Senior trial starts with Supraflex Cruz in Europe
Cruz Senior trial starts with Supraflex Cruz in Europe
Cruz Senior trial starts with Supraflex Cruz in Europe
SMT’s Supraflex Cruz DES Evaluated in European CRUZ SENIOR Trial of Octo- and Nonagenarian Patients
SMT Wins Regional Tenders in Italy for Supraflex Cruz
The Novel Hydra Transcatheter Aortic Valve Demonstrates Favourable Hemodynamic and Low Pacemaker Rate
SMT Completes Enrolment of Cruz HBR Registry
SMT launches TAVR device Hydra in Central Europe
SMT crosses 12,000 implants in DACH within a year of the launch of Supraflex Cruz
SMT announces Supraflex Cruz DES’s Indication-based clinical data at PCR e-Course 2020
SMT receives National reimbursement for Supraflex Cruz heart stent in France to treat people with coronary heart disease
Hydra TAVR System Receives CE Mark Approval to Treat Aortic Stenosis
SMT announces entry in Structural Heart Segment with the acquisition of Vascular Concepts
SMT strengthens presence in Brazil by acquiring Zarek Distribuidora De Produtos Hospitalares
SMT strengthens presence in Brazil by acquiring Zarek Distribuidora De Produtos Hospitalares
Two-year data shows trend towards lower target vessel failure with Indian stent Supraflex vs. Xience stent from Abbott
Two-year data shows trend towards lower target vessel failure with Indian stent Supraflex vs. Xience stent from Abbott
Foundation stone laid for Asia’s largest stent manufacturing unit in Telangana State
Foundation stone laid for Asia’s largest stent manufacturing unit in Telangana State
SMT announces CE* mark for the most deliverable stent Supraflex Cruz
SMT announces CE* mark for the most deliverable stent Supraflex Cruz
Talent Published in The Lancet
Talent Study Gets Published in Renowned Lancet
Italy Tender
SMT SUCCEEDS IN BAGGING ONE MORE TENDER IN ITALY
TALENT Study results
Made in India Supraflex stent clinically at par with Abbott's Xience, finds TALENT Study
Contact:
Pragya C
Assistant General Manager- PR & Corporate Affairs- Global Marketing
pragya.c@smt.in
+91 8733052284
Assistant General Manager- PR & Corporate Affairs- Global Marketing
pragya.c@smt.in
+91 8733052284